STAT1 and glioblastoma: In support of these findings, Ghonime et al. found that glioblastoma (GBM) PDXs tumors with increased STAT1 activity were more resistant to oncolytic virotherapy [50], and concordantly, Kurokawa et al. showed similar findings with sustained interferon signaling [51].